Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
University of Southern California · Fred Hutch Cancer Center · +30 more institutions
Abstract
Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear. We undertook an international collaborative study to assess the association between endometriosis and histological subtypes of ovarian cancer.
Data from 13 ovarian cancer case-control studies, which were part of the Ovarian Cancer Association Consortium, were pooled and logistic regression analyses were undertaken to assess the association between self-reported endometriosis and risk of ovarian cancer. Analyses of invasive cases were done with respect to histological subtypes, grade, and stage, and analyses of borderline tumours by histological subtype. Age, ethnic origin, study site, parity, and duration of oral contraceptive use were included in all analytical models.
Citation impact
- FWCI
- 72.87
- Percentile
- 100%
- References
- 44
Authors
45Topics & keywords
- Endometriosis
- Ovarian cancer
- Medicine
- Serous fluid
- Odds ratio
- Oncology
- Internal medicine
- Case-control study
- Good health and well-being
Funding
- OFOak Foundation
- OCOvarian Cancer Research FundAwards: P50 CA105009, CA58860, CA92044, HEALTH-F2-2009-223175
- CBCalifornia Breast Cancer Research ProgramAwards: 0001389V20170, 2110200
- SOState of Connecticut Department of Public Health
- CDCalifornia Department of Public HealthAward: 050E8709
- RPRoswell Park Alliance Foundation, Roswell Park Cancer Institute
- KBKræftens Bekæmpelse
- DKDeutsches Krebsforschungszentrum
- LVLon V. Smith FoundationAwards: CA92044, HEALTH-F2-2009-223175, CA58860, LVS 39420
- UCUniversity College London
- BFBundesministerium für Bildung und ForschungAwards: HEALTH-F2-2009-223175, CA92044, CA58860
- AUAmerican University of Sharjah
- UOUniversity of South China
- NINational Institutes of HealthAwards: P50 CA136393, R01 CA112523, R01 CA122443, 223175, R01 CA61107, N01 PC35137, R03 CA113148, CA61132, PSA 042205, R01 CA54419, R01 CA126841, R01 CA87538, R01 CA136891, R01 CA95023, CA105009, R01 CA58598, CA122443, P50 CA105009, N01 PC67010, HEALTH-F2-2009-223175, CA58860, N01 CN67001, R01 CA76016, CA14089, CA17054, CA92044, CA136393, 5R01 CA074850
- MRMedical Research CouncilAwards: CA58860, HEALTH-F2-2009-223175, CA92044
- NHNational Health and Medical Research CouncilAward: 199600
- CCCancer Council Tasmania
- SFSeventh Framework ProgrammeAward: HEALTH-F2-2009-223175
- MRMedical Research and Materiel CommandAwards: W81XWH1010280, W81XWH0610220, DAMD17-02-1-0669, CA122443, DAMD 170110729